TransAlta Balance Sheet Health
Financial Health criteria checks 1/6
TransAlta has a total shareholder equity of CA$1.9B and total debt of CA$4.0B, which brings its debt-to-equity ratio to 209.4%. Its total assets and total liabilities are CA$8.7B and CA$6.7B respectively. TransAlta's EBIT is CA$611.0M making its interest coverage ratio 2.6. It has cash and short-term investments of CA$401.0M.
Key information
209.4%
Debt to equity ratio
CA$4.02b
Debt
| Interest coverage ratio | 2.6x |
| Cash | CA$401.00m |
| Equity | CA$1.92b |
| Total liabilities | CA$6.73b |
| Total assets | CA$8.65b |
Recent financial health updates
No updates
Recent updates
TransAlta: The Transition Must Accelerate
Mar 07TransAlta: A Major Player, A Good Buy At Below $10.5/Share
Dec 13TransAlta Q4 2022 Earnings Preview
Feb 22TransAlta declares CAD 0.055 dividend
Dec 12TransAlta prices $400M senior green bond offering
Nov 15TransAlta Q3 2022 Earnings Preview
Nov 07TransAlta Q2 2022 Earnings Preview
Aug 04TransAlta declares CAD 0.05 dividend
Jul 28TransAlta: Renewable Growth Stories At Great Valuations
May 26TransAlta Corp.: A Superior Choice To TransAlta Renewables
Feb 28TransAlta Is Up 40% In 2021 And Is Poised To Repeat It In 2022 With Or Without Acquisition By Brookfield
Dec 14TransAlta Investor Day: Clear Targets And Good Outlook, Though Valuations Are Mixed
Oct 13TransAlta announces NCIB for shares
May 26Financial Position Analysis
Short Term Liabilities: TAC's short term assets (CA$1.7B) do not cover its short term liabilities (CA$2.3B).
Long Term Liabilities: TAC's short term assets (CA$1.7B) do not cover its long term liabilities (CA$4.5B).
Debt to Equity History and Analysis
Debt Level: TAC's net debt to equity ratio (188.5%) is considered high.
Reducing Debt: TAC's debt to equity ratio has increased from 81.1% to 209.4% over the past 5 years.
Debt Coverage: TAC's debt is well covered by operating cash flow (22.2%).
Interest Coverage: TAC's interest payments on its debt are not well covered by EBIT (2.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 04:49 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
TransAlta Corporation is covered by 22 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nathan Heywood | ATB Capital Markets |
| Benjamin Pham | BMO Capital Markets Equity Research |
| Julien Dumoulin-Smith | BofA Global Research |